Article Details
Retrieved on: 2025-01-23 21:26:13
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Applied DNA Sciences Inc.'s challenges in capital markets, including a failed stockholder meeting quorum affecting warrant exercisability, amidst their public offerings, stock volatility on NASDAQ, and potential delisting. The company's financial struggles relate to capital market activities such as equity securities, options, and public offerings.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here